18 Hrs
المصدر:
Financial Times
Novo acquires Chinese weight-loss pill rights
Hengrui Pharma announced that its new drug could potentially be administered once a week. The development aims to improve patient convenience and adherence. Further details on approval or specific indications were not provided.
articleDetails.fontSize.sizeحجم النص
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading